Aquila Biopharmaceuticals Inc - MA Middlesex, Lexington 02421

Aquila Biopharmaceuticals Inc entered the industry of Biological Research in 1994 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 3254140, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.

To acquire more information, please contact Garo H Armen by calling (781) 674-4400 during business hours. You can also write to the business’ Single Location at 3 Forbes Road, Lexington, Massachusetts MA 02421. You can also visit the company’s website at agenusbio.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Aquila Biopharmaceuticals Inc
Representative: Garo H Armen
Place of Business: 3 Forbes Road, Lexington, MA 02421
Contact Number: (781) 674-4400
Website: agenusbio.com
Type of Service: Biological Research
SIC Number: 8731
NAICS Number: 3254140
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1994
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Aquila Biopharmaceuticals Inc is a company operating from Middlesex, Massachusetts providing professional Biological Research and relevant B2B variables. It was founded in 1994 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 3254140 as Biological Research.

With a current employee count of 1 to 4, Aquila Biopharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Garo H Armen at (781) 674-4400 for related queries, or to locate its Single Location using the coordinates 42.44181,-71.26255.

The Single Location can also be found at the street address 3 Forbes Road in Lexington, Massachusetts 02421 and can be engaged online through the company website at agenusbio.com, the company Twitter , and Facebook page .